• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强结构域稳定性并能够作为单链VαVβ片段表达的T细胞受体可变区的结构特征。

Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments.

作者信息

Richman Sarah A, Aggen David H, Dossett Michelle L, Donermeyer David L, Allen Paul M, Greenberg Philip D, Kranz David M

机构信息

Department of Biochemistry, University of Illinois at Urbana-Champaign, 600 S. Mathews Ave., Urbana, IL 61801, USA.

出版信息

Mol Immunol. 2009 Feb;46(5):902-16. doi: 10.1016/j.molimm.2008.09.021. Epub 2008 Oct 29.

DOI:10.1016/j.molimm.2008.09.021
PMID:18962897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2666936/
Abstract

The variable (V) domains of antibodies and T cell receptors (TCRs) share sequence homology and striking structural similarity. Single-chain antibody V domain constructs (scFv) are routinely expressed in a variety of heterologous systems, both for production of soluble protein as well as for in vitro engineering. In contrast, single-chain T cell receptor V domain constructs (scTCR) are prone to aggregation and misfolding and are refractory to display on phage or yeast in their wild-type form. However, through random mutagenesis and yeast display engineering, it has been possible to isolate scTCR mutants that are properly folded and displayed on the yeast surface. These displayed mutants can serve not only as a scaffold for further engineering but also as scTCR variants that exhibit favorable biophysical properties in Escherichia coli expression. Thus, a more comprehensive understanding of the V domain mutations that allowed display would be beneficial. Our goal here was to identify generalizable patterns of important mutations that can be applied to different TCRs. We compared five different scTCRs, four from mice and one from a human, for yeast surface display. Analysis of a collection of mutants revealed four distinct regions of TCR V domains that were most important for enabling surface expression: the Valpha-Vbeta interface, the HV4 of Vbeta, and the region of the Valpha and Vbeta domains normally apposed against the constant (C) domains. Consistent with the role of the V-C interface in surface display, reconstitution of this interface, by including the constant domains of each chain, allowed V domain display and alphabeta chain association on the yeast surface, thus providing an alternative TCR scaffold. However, the surface levels of TCR achieved with engineered scTCR mutants were superior to that of the ValphaCalpha/VbetaCbeta constructs. Therefore, we describe further optimization of the current strategy for surface display of the single-chain format in order to facilitate yeast display engineering of a broader range of scTCRs.

摘要

抗体和T细胞受体(TCR)的可变(V)结构域具有序列同源性和显著的结构相似性。单链抗体V结构域构建体(scFv)通常在多种异源系统中表达,用于生产可溶性蛋白以及体外工程改造。相比之下,单链T细胞受体V结构域构建体(scTCR)易于聚集和错误折叠,并且以野生型形式难以在噬菌体或酵母上展示。然而,通过随机诱变和酵母展示工程,已能够分离出正确折叠并展示在酵母表面的scTCR突变体。这些展示的突变体不仅可以作为进一步工程改造的支架,还可以作为在大肠杆菌表达中表现出良好生物物理特性的scTCR变体。因此,更全面地了解允许展示的V结构域突变将是有益的。我们这里的目标是确定可应用于不同TCR的重要突变的通用模式。我们比较了五种不同的scTCR,其中四种来自小鼠,一种来自人类,用于酵母表面展示。对一组突变体的分析揭示了TCR V结构域中对表面表达最重要的四个不同区域:Vα-Vβ界面、Vβ的HV4以及Vα和Vβ结构域通常与恒定(C)结构域相对的区域。与V-C界面在表面展示中的作用一致,通过包含每条链的恒定结构域来重建该界面,可实现V结构域在酵母表面的展示以及αβ链的缔合,从而提供了一种替代的TCR支架。然而,工程化scTCR突变体在酵母表面实现的TCR水平优于VαCα/VβCβ构建体。因此,我们描述了进一步优化当前单链形式表面展示策略,以促进更广泛范围的scTCR的酵母展示工程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/64ab545e7c16/nihms97104f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/b5ac6e148a66/nihms97104f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/b014f5b26a88/nihms97104f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/98475d72b7e4/nihms97104f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/2ba8c6ea768b/nihms97104f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/3242bf74034e/nihms97104f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/488bc24638d3/nihms97104f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/245785e837a8/nihms97104f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/64ab545e7c16/nihms97104f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/b5ac6e148a66/nihms97104f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/b014f5b26a88/nihms97104f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/98475d72b7e4/nihms97104f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/2ba8c6ea768b/nihms97104f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/3242bf74034e/nihms97104f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/488bc24638d3/nihms97104f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/245785e837a8/nihms97104f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af06/2666936/64ab545e7c16/nihms97104f8.jpg

相似文献

1
Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments.增强结构域稳定性并能够作为单链VαVβ片段表达的T细胞受体可变区的结构特征。
Mol Immunol. 2009 Feb;46(5):902-16. doi: 10.1016/j.molimm.2008.09.021. Epub 2008 Oct 29.
2
Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors.鉴定和工程化允许稳定表达单链 T 细胞受体的人可变区。
Protein Eng Des Sel. 2011 Apr;24(4):361-72. doi: 10.1093/protein/gzq113. Epub 2010 Dec 14.
3
High-level bacterial secretion of single-chain alphabeta T-cell receptors.单链αβ T细胞受体的高水平细菌分泌
J Immunol Methods. 2005 Nov 30;306(1-2):51-67. doi: 10.1016/j.jim.2005.07.022. Epub 2005 Sep 12.
4
An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells.一种优化的单链TCR支架,通过与天然CD3复合物组装,可防止在人T细胞中与内源性TCR发生残留错配。
Oncotarget. 2016 Apr 19;7(16):21199-221. doi: 10.18632/oncotarget.8385.
5
Binding properties and solubility of single-chain T cell receptors expressed in E. coli.在大肠杆菌中表达的单链T细胞受体的结合特性与溶解性
Mol Immunol. 1996 Jun;33(9):819-29. doi: 10.1016/0161-5890(96)00038-7.
6
Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency.酵母多肽融合表面展示水平可预测热稳定性和可溶性分泌效率。
J Mol Biol. 1999 Oct 8;292(5):949-56. doi: 10.1006/jmbi.1999.3130.
7
Subtle changes at the variable domain interface of the T-cell receptor can strongly increase affinity.T 细胞受体可变域界面的细微变化可以显著提高亲和力。
J Biol Chem. 2018 Feb 2;293(5):1820-1834. doi: 10.1074/jbc.M117.814152. Epub 2017 Dec 11.
8
Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1.源自肿瘤浸润淋巴细胞的重组单链T细胞受体以及针对MAGE-1的细胞毒性T淋巴细胞克隆的构建与结合分析
Int Immunol. 1999 May;11(5):745-51. doi: 10.1093/intimm/11.5.745.
9
Structure-Based Rational and General Strategy for Stabilizing Single-Chain T-Cell Receptors to Enhance Affinity.基于结构的理性和通用策略,用于稳定单链 T 细胞受体以增强亲和力。
J Med Chem. 2024 May 9;67(9):7635-7646. doi: 10.1021/acs.jmedchem.4c00503. Epub 2024 Apr 25.
10
Display of functional alphabeta single-chain T-cell receptor molecules on the surface of bacteriophage.功能性αβ单链T细胞受体分子在噬菌体表面的展示。
J Immunol Methods. 1998 Dec 1;221(1-2):59-76. doi: 10.1016/s0022-1759(98)00153-7.

引用本文的文献

1
Temporal TCR dynamics and epitope diversity mark recovery in severe COVID-19 patients.严重 COVID-19 患者的颞部 TCR 动态变化和表位多样性标志着康复情况。
Front Immunol. 2025 Jul 10;16:1582949. doi: 10.3389/fimmu.2025.1582949. eCollection 2025.
2
Strategies and rules for tuning TCR-derived therapy.T 细胞受体(TCR)衍生疗法的优化策略和规则。
Expert Rev Mol Med. 2023 Dec 14;26:e4. doi: 10.1017/erm.2023.27.
3
Circulating pre-treatment T-cell receptor repertoire as a predictive biomarker in advanced or metastatic non-small-cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy.

本文引用的文献

1
Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes.恢复T细胞受体与CD8的关联可逆转人类肿瘤浸润淋巴细胞的无反应性。
Immunity. 2008 Mar;28(3):414-24. doi: 10.1016/j.immuni.2008.01.011.
2
A new twist in TCR diversity revealed by a forbidden alphabeta TCR.一种被禁止的αβ TCR揭示的TCR多样性新变化。
J Mol Biol. 2008 Feb 1;375(5):1306-19. doi: 10.1016/j.jmb.2007.11.020. Epub 2007 Nov 17.
3
How a single T cell receptor recognizes both self and foreign MHC.单个T细胞受体如何识别自身和外来的主要组织相容性复合体。
循环预处理 T 细胞受体库作为预测标志物,用于评估单独使用派姆单抗或联合化疗治疗晚期或转移性非小细胞肺癌患者的疗效。
ESMO Open. 2023 Dec;8(6):102066. doi: 10.1016/j.esmoop.2023.102066. Epub 2023 Nov 22.
4
Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cells.当前和未来用于生成和应用基因工程 CAR-T 和 TCR-T 细胞的概念。
Front Immunol. 2023 Mar 6;14:1121030. doi: 10.3389/fimmu.2023.1121030. eCollection 2023.
5
The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers.多价 γδ TCR 抗 CD3 双特异性 T 细胞衔接子的构建。
Front Immunol. 2023 Jan 5;13:1052090. doi: 10.3389/fimmu.2022.1052090. eCollection 2022.
6
Emerging Strategies in TCR-Engineered T Cells.T 细胞受体工程化细胞中的新兴策略。
Front Immunol. 2022 Mar 30;13:850358. doi: 10.3389/fimmu.2022.850358. eCollection 2022.
7
Rapid screening of TCR-pMHC interactions by the YAMTAD system.利用YAMTAD系统快速筛选TCR-pMHC相互作用
Cell Discov. 2022 Apr 5;8(1):30. doi: 10.1038/s41421-022-00386-2.
8
The Full Model of the pMHC-TCR-CD3 Complex: A Structural and Dynamical Characterization of Bound and Unbound States.pMHC-TCR-CD3 复合物的全模型:结合态和游离态的结构与动态特征描述。
Cells. 2022 Feb 14;11(4):668. doi: 10.3390/cells11040668.
9
Engineering soluble T-cell receptors for therapy.工程化可溶性 T 细胞受体治疗。
FEBS J. 2021 Nov;288(21):6159-6173. doi: 10.1111/febs.15780. Epub 2021 Mar 10.
10
CD4 Inhibits Helper T Cell Activation at Lower Affinity Threshold for Full-Length T Cell Receptors Than Single Chain Signaling Constructs.CD4 在较低亲和力阈值下抑制辅助 T 细胞活化,比单链信号结构更能抑制全长 T 细胞受体。
Front Immunol. 2021 Jan 19;11:561889. doi: 10.3389/fimmu.2020.561889. eCollection 2020.
Cell. 2007 Apr 6;129(1):135-46. doi: 10.1016/j.cell.2007.01.048.
4
Disruption of extracellular interactions impairs T cell receptor-CD3 complex stability and signaling.细胞外相互作用的破坏会损害T细胞受体-CD3复合物的稳定性和信号传导。
Immunity. 2007 Mar;26(3):357-69. doi: 10.1016/j.immuni.2007.01.015.
5
A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule.T细胞受体使主要组织相容性复合体I类分子呈递的凸起抗原肽变平。
Nat Immunol. 2007 Mar;8(3):268-76. doi: 10.1038/ni1432. Epub 2007 Jan 28.
6
Crystal structure of a complete ternary complex of TCR, superantigen and peptide-MHC.TCR、超抗原和肽-MHC完整三元复合物的晶体结构。
Nat Struct Mol Biol. 2007 Feb;14(2):169-71. doi: 10.1038/nsmb1193. Epub 2007 Jan 14.
7
The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy.对高亲和力T细胞受体的研究揭示了T细胞对抗原识别的双重性:特异性和简并性。
J Immunol. 2006 Nov 15;177(10):6911-9. doi: 10.4049/jimmunol.177.10.6911.
8
Facilitating matched pairing and expression of TCR chains introduced into human T cells.促进引入人T细胞中的TCR链的匹配配对和表达。
Blood. 2007 Mar 15;109(6):2331-8. doi: 10.1182/blood-2006-05-023069. Epub 2006 Nov 2.
9
The structure of the zetazeta transmembrane dimer reveals features essential for its assembly with the T cell receptor.ζζ跨膜二聚体的结构揭示了其与T细胞受体组装所必需的特征。
Cell. 2006 Oct 20;127(2):355-68. doi: 10.1016/j.cell.2006.08.044.
10
Cancer regression in patients after transfer of genetically engineered lymphocytes.基因工程淋巴细胞转移后患者的癌症消退。
Science. 2006 Oct 6;314(5796):126-9. doi: 10.1126/science.1129003. Epub 2006 Aug 31.